Mitsubishi UFJ Asset Management
ARCT icon

Mitsubishi UFJ Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,693
Closed -$156K – 1616
2025
Q1 		$156K Buy
14,693
+1,232
+9% +$19.6K ﹤0.01% 984
2024
Q4 		$241K Buy
13,461
+4,647
+53% +$87.5K ﹤0.01% 964
2024
Q3 		$205K Sell
8,814
-832
-9% -$17.8K ﹤0.01% 961
2024
Q2 		$235K Buy
9,646
+7
+0.1% +$212 ﹤0.01% 947
2024
Q1 		$326K Sell
9,639
-441
-4% -$15.6K ﹤0.01% 916
2023
Q4 		$316K Sell
10,080
-773
-7% -$18.4K ﹤0.01% 968
2023
Q3 		$277K Buy
10,853
+606
+6% +$18.7K ﹤0.01% 991
2023
Q2 		$294K Sell
10,247
-6,581
-39% -$179K ﹤0.01% 988
2023
Q1 		$403K Buy
16,828
+1,038
+7% +$18.6K ﹤0.01% 945
2022
Q4 		$264K Buy
15,790
+1,875
+13% +$32.7K ﹤0.01% 993
2022
Q3 		$206K Hold
13,915
– – ﹤0.01% 1018
2022
Q2 		$219K Buy
13,915
+5,617
+68% +$110K ﹤0.01% 1033
2022
Q1 		$224K Buy
8,298
+687
+9% +$17.5K ﹤0.01% 1038
2021
Q4 		$301K Sell
7,611
-2,790
-27% -$114K ﹤0.01% 1008
2021
Q3 		$497K Buy
10,401
+270
+3% +$12.1K ﹤0.01% 944
2021
Q2 		$343K Buy
+10,131
New +$343K ﹤0.01% 1016

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mitsubishi UFJ Asset Management's ARCT Position: Q2 2025 in Review

Mitsubishi UFJ Asset Management sold out of Arcturus Therapeutics (ARCT) in Q2 2025, closing a stake of 14,693 shares — an estimated $156K sold.

Mitsubishi UFJ Asset Management first reported a position in ARCT in Q2 2021 and held it in 16 quarters. The position peaked at $497K in Q3 2021. 143 funds tracked by Wall St. Rank hold ARCT as of Q2 2025.

  • Mitsubishi UFJ Asset Management reported no remaining Arcturus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 14,693 Arcturus Therapeutics shares in Q2 2025, an estimated $156K.
  • Mitsubishi UFJ Asset Management first reported a position in Arcturus Therapeutics in Q2 2021 and held it in 16 quarters.
  • Mitsubishi UFJ Asset Management's Arcturus Therapeutics position peaked at $497K in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2025.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.